Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-06-15

Clinical Trial Update: COVID19 SARS Vaccinations: Systemic Allergic Reactions to SARS-CoV-2 Vaccinations [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update reports systemic allergic reactions related to SARS-CoV-2 vaccinations, with results posted in June 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SARS-CoV-2 vaccine

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: SARS-CoV Infection, COVID-19 | Phase 2 | Status: COMPLETED | Results posted: 2023-06-15